Valuation: Hikma Pharmaceuticals PLC

Market Cap 4.7B 4.03B 3.78B 3.45B 6.51B 448B 6.58B 44.55B 17.34B 226B 17.66B 17.28B 749B P/E 2026 *
12.2x
P/E 2027 * 10.8x
Enterprise Value 6.17B 5.29B 4.96B 4.53B 8.54B 588B 8.63B 58.46B 22.76B 297B 23.18B 22.67B 983B EV / Sales 2026 *
1.78x
EV / Sales 2027 * 1.67x
Free-Float
63.21%
Yield 2026 *
3.86%
Yield 2027 * 4.09%
1 day+0.15%
1 week+0.06%
Current month+3.47%
1 month+3.67%
3 months+12.41%
6 months-0.79%
Current year+5.81%
1 week 1,607.8
Extreme 1607.8
1,669
1 month 1,563
Extreme 1563
1,755
Current year 1,187
Extreme 1187
1,762
1 year 1,187
Extreme 1187
1,865
3 years 1,187
Extreme 1187
2,360
5 years 1,174.5
Extreme 1174.5
2,625
10 years 814.2
Extreme 814.2
2,768
Manager TitleAgeSince
Chief Executive Officer 69 2025-11-30
Director of Finance/CFO - 2026-02-25
Chief Tech/Sci/R&D Officer 64 2026-02-25
Director TitleAgeSince
Director/Board Member 69 2005-10-13
Director/Board Member 54 2025-12-14
Chairman 69 2014-05-14
Date Insider Type Main position Quantity % Market Cap.
12/19/25 Buy

Director

100,000 0.0451%
11/11/25 Buy

Chief Executive Officer

70,000 0.0315%
11/11/25 Buy

Chief Executive Officer

100,000 0.0451%
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%+0.06%-10.68%-21.76% 4.69B
-1.06%+0.65%+77.42%+122.82% 1,111B
+0.53%+0.75%+53.10%+64.29% 658B
+0.48%+2.65%+28.06%+81.19% 467B
+0.92%+4.97%+42.94%+43.69% 369B
+1.25%+4.00%+25.87%+42.82% 301B
+3.02%+7.92%+4.24%+16.06% 256B
-0.36%+3.99%+53.31%+72.49% 240B
+2.86%+5.27%-15.42%-52.34% 207B
+1.38%+3.72%+30.33%+93.56% 182B
Average +0.95%+4.01%+28.92%+46.28% 379.57B
Weighted average by Cap. +0.62%+4.67%+45.81%+72.02%

Financials

2026 *2027 *
Net sales 3.46B 2.97B 2.78B 2.54B 4.79B 330B 4.84B 32.79B 12.77B 167B 13B 12.72B 552B 3.6B 3.09B 2.89B 2.64B 4.99B 343B 5.03B 34.11B 13.28B 173B 13.52B 13.23B 574B
Net income 412M 353M 331M 302M 571M 39.3B 576M 3.9B 1.52B 19.83B 1.55B 1.51B 65.66B 453M 389M 364M 333M 628M 43.23B 634M 4.29B 1.67B 21.81B 1.7B 1.67B 72.22B
Net Debt 1.47B 1.26B 1.18B 1.08B 2.03B 140B 2.05B 13.91B 5.42B 70.65B 5.51B 5.39B 234B 1.29B 1.11B 1.04B 949M 1.79B 123B 1.81B 12.25B 4.77B 62.21B 4.86B 4.75B 206B
Logo Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company engaged in the development, manufacturing and marketing of a broad range of generic, branded and specialty pharmaceutical products. Its pharmaceutical operations are conducted through three business segments: Injectables, Branded and Hikma Rx. It supplies hospitals across North America, Europe and the Middle East and North Africa (MENA) region with generic injectable and specialty medicines, supported by its growing global manufacturing network. It supplies branded generic and in-licensed products from its local manufacturing facilities to retail and hospital customers across the MENA region. Through Hikma Rx, it supplies oral, respiratory and other generic and specialty products to the North American market. Its manufacturing facilities in the United States (US) supply products across a broad range of therapeutic areas, including respiratory, oncology and pain management, serving customers in both the US and Canada.
Employees
9,500
Date Price Change Volume
26-08-25 GBX 1,640.00 +0.43% 308,611
26-08-24 GBX 1,633.00 -0.18% 680,937
26-08-21 GBX 1,636.00 +0.74% 511,578
26-08-20 GBX 1,624.00 -2.05% 458,598
26-08-19 GBX 1,658.00 +0.36% 567,937
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
22.28USD
Average target price
25.78USD
Spread / Average Target
+15.72%

Quarterly revenue - Rate of surprise